The core of atopy is a Type I hypersensitivity reaction driven by a Type 2 immune response.
: Systemic immune priming eventually leads to upper and lower airway inflammation. 3. Key Management Strategies The core of atopy is a Type I
While there is currently no cure, management focuses on controlling inflammation and restoring barrier function. Atopy - StatPearls - NCBI Bookshelf - NIH Key Management Strategies While there is currently no
Atopy is a genetic predisposition toward developing exaggerated IgE-mediated immune responses to common environmental allergens. Clinically, it manifests as a triad of conditions—, allergic rhinitis (hay fever) , and allergic asthma —often appearing sequentially in a pattern known as the "atopic march". 1. Pathophysiology and Mechanism The Atopic March
Atopy typically follows a predictable chronological progression:
: Upon re-exposure, allergens cross-link IgE on the surface of mast cells, causing degranulation and the release of inflammatory mediators like histamine and leukotrienes. 2. The Atopic March